Related Experiment Video
Updated: Jun 12, 2026
06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions
Rohini Chakravarthy1, Monica M Laronda2, Sara Zarnegar-Lumley3
1Division of Hematology and Oncology, Department of Pediatrics, Comer Children's Hospital, University of Chicago School of Medicine, University of Chicago, 5837 South Maryland Avenue Wyler C-425B, Chicago, IL 60637, USA.
Hematology/Oncology Clinics of North America
|June 10, 2026
Summary
Childhood cancer survivors prioritize fertility and reproductive health. Continued research and advocacy are crucial to overcome barriers and ensure access to fertility preservation options for all patients.
Area of Science:
- Oncology
- Reproductive Medicine
- Oncofertility
Background:
- Reproductive health and fertility are vital for childhood cancer survivors' quality of life.
- Oncofertility has advanced significantly, improving fertility preservation options.
- Despite progress, barriers to fertility care persist, and long-term outcomes are often unknown.
Purpose of the Study:
- To highlight the importance of fertility considerations in cancer survivorship.
- To review advancements in oncofertility and remaining challenges.
- To advocate for continued research and equitable access to reproductive health services.
Main Methods:
- Literature review on oncofertility advancements.
- Analysis of current barriers in fertility preservation.
- Discussion of the need for ongoing research and advocacy.
Main Results:
- Oncofertility has developed risk stratification and multidisciplinary care models.
- Fertility preservation is increasingly prioritized for cancer patients.
- Significant barriers remain, impacting long-term success and access.
Conclusions:
- Ensuring access to reproductive health care is essential for cancer survivors.
- Further research is needed to understand long-term fertility preservation success rates.
- Advocacy efforts must continue to address existing barriers and promote comprehensive survivorship care.
Related Concept Videos
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...